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Background: Improved methods of cardiac allograft protection are required to
expand the pool of potentially available organs and to enhance the recovery of grafts
subjected to prolonged ischemia. We have previously demonstrated that limited
coronary perfusion provided by donor blood harvested at the time of organ pro-
curement can improve both metabolic and functional recovery after transplantation.
In this study we evaluated the hypothesis that limited coronary perfusion may
enable prolonged cardiac storage while avoiding the potentially detrimental effects
of profound hypothermia.
Methods: Fourteen orthotopic cardiac transplants were performed in female
Yorkshire pigs by using donor blood perfusion during 5 hours of either tepid (25°C)
or cold (4°C) storage. Assessments of myocardial metabolism and function were
performed at baseline and after 45 minutes of normothermic (37°C) reperfusion.
Results: Hearts protected with tepid perfusion displayed improved recovery of
myocardial function (89% ± 18% vs 63% ± 25%, P = .05). Diastolic compliance
was adversely affected in both groups after transplantation. Aerobic myocardial
metabolism was better preserved in the tepid group.
Conclusions:  Profound hypothermia results in depressed myocardial metabolic and
functional recovery after transplantation. Limited coronary perfusion with shed
donor blood can permit cardiac allograft storage at tepid temperatures, resulting in
improved myocardial performance.
Orthotopic cardiac transplantation remains a proven therapy forend-stage heart disease. Unfortunately, the limited supply of suit-able donor organs has resulted in an increase in the average wait-ing time for recipients. A recent report by Hauptman and col-leagues1 demonstrated that the average waiting time for stable(out-of-hospital) patients has increased from 88 ± 13 days to 146
± 15 days over a 10-year period. In an attempt to increase the pool of available
organs, several centers have extended the criteria for suitable allografts. The report
by Hauptman and colleagues recognized this trend with an increased use of older
donors, greater weight differences between donor and recipient, and a shift toward
longer ischemic times (152 ± 4 vs 180 ± 4 minutes, P < .0001). Unfortunately, all
of these factors may increase the perioperative risk of cardiac transplantation.
The primary cause of early morbidity and mortality after cardiac transplantation
continues to be primary graft dysfunction. In a recent registry report from the
International Society for Heart and Lung Transplantation, primary graft dysfunction
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was responsible for almost 50% of the early mortality after
isolated heart transplantation.2 Improved methods of allograft
preservation are required to prevent primary graft dysfunction
so that marginal donor organs can continue to be used.
We have previously developed a technique to harvest
shed donor blood from the chest cavity at the time of organ
procurement for subsequent allograft perfusion during stor-
age.3,4 In a porcine model of orthotopic cardiac transplanta-
tion, we found that a simple perfusion apparatus making use
of unoxygenated donor blood provided superior myocardial
protection compared with our current clinical technique of
static hypothermic storage.3 However, we noted persistent
inhibition of normal aerobic myocardial metabolism, which
led to depressed left ventricular functional recovery after
transplantion. In an attempt to reverse the inhibition of aer-
obic metabolism, we supplemented our blood perfusate with
insulin.4 Insulin-treated hearts displayed greater oxygen
extraction than control blood-perfused hearts but only after
a normothermic infusion of blood cardioplegic solution. The
increase in myocardial oxygen extraction resulted in
improved functional recovery.
In previous studies with blood perfusion, the average coro-
nary flow rate during storage was less than 15 mL/min at a
myocardial temperature of 4°C. Buckberg and colleagues’5
classic description of myocardial metabolism during cardio-
plegic arrest demonstrated that oxygen consumption in the nor-
mothermic arrested heart was reduced by 80% compared with
that in the empty beating state. The addition of mild hypother-
mia (22°C) reduced oxygen consumption by an additional 15%.
On the basis of these observations, we hypothesized that the
limited coronary flow provided by our perfusion apparatus may
be sufficient to support aerobic myocardial metabolism at room
temperature (25°C-27°C). Our previous clinical experience in
coronary bypass operations suggested that hypothermic cardio-
plegic arrest produced a delay in myocardial metabolic and
functional recovery that was partially prevented by the use of
normothermic blood cardioplegia.6
The present study was designed to evaluate myocardial
metabolic and functional recovery after orthotopic cardiac
transplantation in a porcine model by using donor blood per-
fusion and storage at profound hypothermia (4°C) versus at
mild hypothermia (25°C-27°C).
Methods
The experimental protocol was approved by our institutional ani-
mal care committee and was in accordance with the “Guide for the
Care and Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources, National Research Council, and
published by the National Academy Press, revised 1996. Twenty-
eight female Yorkshire pigs (50-60 kg) were used to perform 14
orthotopic cardiac transplants with either profound hypothermia
(cold, 4°C; n = 7) or mild hypothermia (tepid, 25°C; n = 7). The
size mismatch between donor and recipient was less than 5% of
body weight in all experiments.
Donor Operation
The animals were anesthetized with intramuscular ketamine (30
mg/kg) and isoflurane and intubated and ventilated with 100% oxy-
gen to maintain normocarbia. After sternotomy, the heart and great
vessels were exposed. Systemic anticoagulation was achieved with
the intravenous injection of 10,000 units of heparin.
A purse-string suture was placed in the ascending aorta to permit
placement of a cardioplegia cannula. Arterial and coronary sinus
blood samples were obtained just before aortic crossclamping, and
then 1 L of a hyperkalemic crystalloid solution (Na+, 127 mmol/L;
K+, 20 mmol/L; Mg2+, 6 mmol/L; Cl–, 7 mmol/L; SO4–, 6 mmol/L
tris-hydroxymethyl aminomethane, 4 mmol/L; and dextrose, 135
mmol/L) was infused into the aortic root to achieve cardioplegic
arrest. In the cold group cardioplegic solution was infused at 4°C, and
then the donor heart was extracted, placed in a bag containing 300
mL of hypothermic cardioplegic solution, and stored on ice. In the
tepid group cardioplegic solution was infused at room temperature
(25°C), and after extraction, the donor heart was stored in a plastic
bag containing 300 mL of room temperature cardioplegic solution.
The cardioplegia cannula and aortic crossclamp were left in place in
all hearts to permit donor blood perfusion during storage.
In both groups donor blood was harvested from the chest after organ
extraction. After filtration for particulate matter and the addition of
10,000 units of heparin, the blood was stored in standard transfusion
bags (Travenol; Baxter Healthcare Corp, Deerfield, Ill). Blood perfusion
was initiated within 10 minutes of cardioplegic arrest and was delivered
at room temperature (20°C) at a vertical height of 100 cm (to correspond
to a perfusion pressure of 60 mm Hg) by using a standard intravenous
transfusion apparatus (Fenwal, Baxter Healthcare Corp).3,4 Blood per-
fusion was maintained in all hearts throughout the 5-hour storage peri-
od before commencing the recipient operation. A myocardial probe was
inserted into the apex of the left ventricle in all hearts to monitor tem-
perature during storage. In the cold group myocardial temperatures were
maintained between 4°C and 7°C with topical iced saline solution, and
in the tepid group the apical temperature was allowed to equilibrate with
room temperature. Coronary flow rate was determined as the total vol-
ume of perfusate delivered corrected for storage time in minutes.
Recipient Operation
Preoperative sedation and anesthesia were performed as in the donor
protocol. In addition, a marginal ear vein was used for intravenous
access and kept open with a 50 mL/h 5% dextrose infusion.
Continuous electrocardiographic monitoring was used, and a carotid
artery line was inserted to measure arterial pressure.
After sternotomy, the heart and great vessels were exposed.
Umbilical tapes were placed around the superior and inferior venae
cavae. Systemic anticoagulation was achieved by injecting heparin into
the pump prime (10,000 U) in addition to an intravenous dose of
10,000 U. Ascending aortic and bicaval cannulation were used to place
the recipient on cardiopulmonary bypass. Flow rates were adjusted to
maintain systemic perfusion pressures above 50 mm Hg. No vasoac-
tive medications were administered during cardiopulmonary bypass.
Systemic perfusion was maintained at 37°C in both groups.
After the aorta was crossclamped, the recipient heart was extract-
ed, maintaining a cuff of right and left atrium. The left hemiazygos
vein was ligated at its insertion into the coronary sinus. The anasto-
motic margins were then inspected and trimmed in preparation for
orthotopic transplantation by a standard atrial-to-atrial technique.3,4
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In all groups donor blood perfusion of the allograft was stopped,
and an initial 350-mL blood cardioplegic dose was infused at a flow
rate of 100 mL/min. Cardioplegic protection consisted of a 2:1 mix-
ture of blood/crystalloid and was delivered at 4°C or 27°C, depend-
ing on the randomization group. Cardioplegic solution was infused
after the completion of each atrial anastomosis and the pulmonary
arterial anastomosis. Arterial and coronary sinus blood samples were
obtained at each cardioplegic infusion, at the time of crossclamp
removal, and every 15 minutes during reperfusion. If ventricular fib-
rillation occurred during reperfusion, 3 attempts were made to defib-
rillate the heart. If unsuccessful, 100 mg of lidocaine was delivered
intravenously, and defibrillation was attempted once again.
At the completion of 45 minutes of reperfusion on cardiopul-
monary bypass, hemodynamic measurements were obtained. After
completion of all measurements, the recipient was weaned off bypass
if possible. In all hearts calcium chloride (1 g) was given, and if addi-
tional inotropic support was required, an isoproterenol (INN: isopren-
aline) drip was established (0.4 mg/min). If a mean arterial pressure
greater than 60 mm Hg could not be maintained for 30 minutes
despite inotropic support, weaning was deemed to be unsuccessful.
Ventricular pacing was used if necessary to maintain the heart rate at
greater than 80 beats/min. Thirty minutes after discontinuation of car-
diopulmonary bypass, decannulation was performed, and the animal
was killed by means of intravenous potassium chloride injection.
Assessment of Left Ventricular Function
A fluid-filled latex balloon connected to a Millar micromanometer
catheter (Millar Instruments, Inc, Houston, Tex) was inserted through
the apex of the left ventricle to permit on-line measurements of heart
rate and left ventricular systolic and diastolic pressures.
Measurements of left ventricular end-systolic pressure, left ventricu-
lar end-diastolic pressure (LVEDP), and developed pressure (DP)
were performed at 5-mL increments as the balloon volume was
increased from 0 to 50 mL.
In addition to the assessment of the pressure-volume relation-
ships, the average recovery of DP was calculated as the ratio of the
postreperfusion DP to the baseline DP at the same balloon volume.
The average percentage recovery of developed pressure (%DP) was
determined by means of the trapezoidal rule, as described previously
by Jayawant and colleagues:7
%DP = (100)∫VaVb[DP(Postreperfusion)/DP
(baseline) · dV/(Vb – Va)]
where Va is the smallest matching postreperfusion balloon volume
and Vb is the largest matching postreperfusion balloon volume.
This integration of the pressure-volume curve is a surrogate mea-
surement of myocardial work and was performed both before and
after transplantation.
Similarly, the change in diastolic compliance after transplantation
was calculated by determining the ratio of the integrated areas of the
postreperfusion and baseline LVEDP-balloon volume relationship:
Mean LVEDP ratio = ∫VaVb[PR/PB · dV/(Vb – Va)]
where PB is the LVEDP at baseline and PR is the LVEDP after
reperfusion. The mean LVEDP ratio reflects the average change in
LVEDP for a given change in balloon volume corrected for the pre-
transplant compliance. Therefore, a ratio of 1 indicates that the
change in LVEDP for a given change in balloon volume was iden-
tical before and after transplantation with no change in diastolic
compliance. A ratio greater than 1 is indicative of decreased dia-
stolic compliance.
Biochemical Measurements
Arterial and coronary sinus blood samples were assayed for the
PO2, PCO2, pH, hemoglobin concentration (Hb), and oxygen satu-
ration (SaO2). Oxygen content (O2Con) was calculated from the
following formula:
O2Con = 1.39 Hb · Sao2 + 0.003 · Po2.
Blood samples for lactate determination were mixed with a mea-
sured volume of 6% perchloric acid. Lactate concentration was mea-
sured in the protein-free supernatant with a commercially available
assay (Rapid Lactate Stat Pack; Calbiochem-Behring, La Jolla, Calif).
Figure 1. Recovery of DP in hearts perfused at hypothermic (cold,
4°C) versus tepid (25°C) temperatures. Post-transplantation DP
was lower in both groups.
Figure 2. Average recovery of left ventricular DP. Hearts in the
tepid group displayed significantly better recovery of function
compared with hearts in the cold group (89% ± 18% vs 63% ± 25%,
P = .046).
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Statistical Analysis
Statistical analysis was performed with the SAS statistical soft-
ware program (SAS Institute, Inc, Cary, NC). Categorical data
were analyzed by the 2-tailed Fisher exact test. The left ventricular
DP–balloon volume relation was analyzed with 2-way analysis of
variance (ANOVA), evaluating the main effects of group and bal-
loon volume. Similarly, 2-way ANOVA was used to evaluate the
LVEDP–balloon volume relation. The average recovery of DP and
the mean LVEDP ratio were analyzed with paired t tests.
Continuous metabolic data are expressed as the mean ± stan-
dard deviation and were analyzed with 2-way ANOVA, evaluating
the main effects of group and time, as well as the interactive effect
between group and time (group · time). When appropriate, a post
hoc Duncan multiple-range test was performed to specify differ-
ences between groups.
Results
All hearts in both groups were successfully weaned from
cardiopulmonary bypass. Inotropic support was required to
wean from cardiopulmonary bypass more frequently in the
cold group (4/7 vs 2/7, P = .59). Similarly, more hearts in the
cold group required lidocaine therapy than in the tepid group
(7/7 vs 3/7, P = .02). There was no difference between
groups in heart rate, either before or after transplantation.
Recovery of Left Ventricular Function
Figure 1 shows the DP-balloon volume relationship before
and after transplantation in both groups. There was no sig-
nificant interactive effect between group and balloon volume
either before (group · volume: F = 1.57, P = .213) or after (F
= 0.04, P = .847) transplantation. The integrated DP-volume
relation was not different between groups before transplanta-
tion (cold: 4110 ± 952 mm Hg/mL vs tepid: 4090 ± 538 mm
Hg/mL, P = .96); however, this value trended higher in the
tepid group after transplantation (3805 ± 906 mm Hg/mL vs
2791 ± 999 mm Hg/mL, P = .07) Figure 2 shows the average
percentage recovery of DP in both groups after transplanta-
tion. When corrected for pretransplantation values, hearts in
the tepid group displayed significantly better recovery of
myocardial function than hearts in the cold group (89% ±
18% vs 63% ± 25%, P = .046).
Figure 3 illustrates the LVEDP–balloon volume relation-
ship before and after transplantation in both groups. There
was no significant interactive effect between group and bal-
loon volume before transplantation (group · volume: F =
1.6, P = .208); however, there was a significant interactive
effect after transplantation and reperfusion (F = 9.29, P =
.003). The diastolic pressure-volume relationship was sig-
nificantly worse in the cold group. Figure 4 displays the
mean LVEDP ratio in both groups. Hearts in both groups
displayed diastolic dysfunction after transplantation (ratio
>1), but there were no significant differences between
groups (P = .985).
Recovery of Myocardial Metabolism
Figure 5 demonstrates myocardial lactate release–extraction
during the experimental protocol. There was no interactive
effect between group and time (group · time effect: F = 1.04,
P = .414); however, lactate release increased significantly
after storage and then returned to baseline values after 45
minutes of reperfusion (time effect: F = 2.56, P = .013).
There were no differences in lactate release between groups
at any time point (group effect: F = 0.05, P = .830).
Figure 6 demonstrates myocardial acid release (pH dif-
ference between arterial and coronary sinus blood) during
the experimental protocol. There was no significant interac-
tive effect between group and time (group · time effect: F =
1.40, P = .204); however, acid release increased in both
groups after the initial cardioplegic infusion, returning to
baseline levels after reperfusion (time effect: F = 7.57, P <
Cardiothoracic Transplantation Rao et al
Figure 3. Change in diastolic compliance after transplantation.
Diastolic compliance worsened in both groups after transplantation.
Figure 4. LVEDP ratio after transplantation. A given change in bal-
loon volume resulted in a 21% increase in LVEDP compared with
pretransplantation changes in the cold group compared with an
18% increase in the tepid group (P = .28).
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.001). There was an overall trend toward greater acid release
in the cold group (group effect: F = 3.37, P = .069).
Figure 7 demonstrates myocardial oxygen extraction
during the experimental protocol. There was no significant
interactive effect between group and time (group · time
effect: F = 0.78, P = .618); however, myocardial oxygen
extraction was severely inhibited in both groups during car-
dioplegic arrest (time effect: F = 15.59, P < .001). Hearts
that received tepid perfusion demonstrated improved
myocardial oxygen extraction compared with hearts that
were perfused at cold temperatures (group effect: F =
16.70, P < .001).
Discussion
Primary graft dysfunction remains the predominant cause of
perioperative death after cardiac transplantation.2 Improved
methods of myocardial preservation during allograft pro-
curement and storage are therefore required to reduce the
risk of early death. In addition, recent evidence suggests that
perioperative ischemic-reperfusion injury may influence the
late development of graft vascular disease.8 Graft vascular
disease represents the leading cause of late death after heart
transplantation.2 Thus, novel techniques of organ preserva-
tion may lead to improvement in both short- and long-term
survival after transplantation.
Several investigators have reported the beneficial effects
of allograft perfusion during storage.9-14 Unfortunately, the
perfusion systems described by these authors have not
become widely adopted because of either cost, lack of
portability, or complexity. We have previously described a
simple technique of organ perfusion that makes use of donor
blood harvested from the mediastinum at the time of organ
procurement.3,4 Although perfusion with donor blood pro-
vided superior myocardial protection compared with our
clinical technique of static hypothermic storage, we noted
persistent inhibition of normal aerobic myocardial metabo-
lism, which led to depressed left ventricular functional
recovery after transplantation. In previous cell-culture stud-
ies we demonstrated that insulin was capable of stimulating
aerobic metabolism in human ventricular cardiomyocytes
subjected to ischemia and reperfusion.15 Therefore, in an
attempt to reverse the metabolic inhibition observed in our
porcine studies, we supplemented our blood perfusate with
insulin and found that transplanted hearts displayed greater
oxygen extraction than control blood-perfused hearts.
However, this metabolic difference occurred only after a
normothermic infusion of blood cardioplegic solution near
the end of organ implantation. The increase in myocardial
oxygen extraction resulted in a further improvement of
functional recovery.
We hypothesized that maintaining higher temperatures
during organ storage and implantation may permit higher
myocardial oxygen extraction and lead to improved func-
tional recovery after reperfusion. Because our primary focus
was to develop a simplified, clinically useful perfusion
apparatus, we chose to compare hearts stored at profoundly
hypothermic temperatures (4°C, which is similar to our cur-
rent clinical practice) with hearts that were stored at tem-
peratures of 25°C to 27°C. We were able to achieve this
level by simply allowing the apical temperature to equili-
Figure 5. Myocardial lactate release during the experimental pro-
tocol. Lactate release increased significantly during storage and
implantation but returned to baseline after 45 minutes of reperfu-
sion. There were no differences between groups at any time point.
PRE, Baseline; XCL, cardioplegic arrest; LA, completion of left
atrial anastomosis; RA, completion of right atrial anastomosis; PA,
completion of pulmonary anastomosis; OFF, removal of aortic
crossclamp; 15, 30, and 45, minutes of reperfusion.
Figure 6. Myocardial acid release (difference in aortic and coronary
sinus pH) during the experimental protocol. Acid release increased
during storage and implantation but returned to baseline values
after reperfusion. There were no differences between groups at any
time point. PRE, Baseline; XCL, cardioplegic arrest; LA, completion
of left atrial anastomosis; RA, completion of right atrial anastomo-
sis; PA, completion of pulmonary anastomosis; OFF, removal of aor-
tic crossclamp; 15, 30, and 45, minutes of reperfusion.
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brate with room temperature. This avoided complicating our
apparatus with cumbersome heater-cooler machinery. In
previous studies we found that cooling the donor blood per-
fusate to 4°C resulted in rouleau formation and an unac-
ceptable viscosity.3,4 Therefore, in both groups the blood
perfusate was delivered at room temperatures. However,
measurements of the left ventricle, right ventricle, and inter-
ventricular septum confirmed profoundly hypothermic
(4°C) temperatures in the cold group compared with tem-
peratures of 27°C in the tepid group.
Previous studies examining the optimal storage tempera-
tures have yielded conflicting results.16-19 Hendry and col-
leagues16 demonstrated, in an ultrastructural canine study,
that current techniques of hypothermic storage result in
unacceptably low myocardial temperatures that cause
reversible myocardial injury. In a subsequent functional
study Hendry and colleagues17 showed that myocardial
preservation at 4°C versus 12°C resulted in similar preser-
vation of intracellular energy stores and functional recovery.
A study by Suehiro and colleagues18 demonstrated that
warm blood perfusion (25°C) in a canine model of 60-
minute global ischemia provided superior protection to
hypothermic (4°C) preservation in University of Wisconsin
solution. In contrast, studies by Masters and colleagues19
and Ueno and colleagues12 both demonstrated that storage
temperatures of 4°C resulted in the optimal recovery of
myocardial function. However, the study by Masters and
colleagues19 did not include myocardial perfusion during
storage, which may have adversely affected the group sub-
jected to 15°C storage. In the study by Ueno and col-
leagues,12 which used continuous perfusion for 24 hours in
a rabbit model, the authors compared storage at 0°C, 4°C,
and 10°C. They found that the intermediate temperature
provided optimal protection but did not evaluate continuous
perfusion at higher temperatures similar to that used in our
present protocol. Furthermore, anatomic differences
between rabbit, canine, and human myocardium make it dif-
ficult to extrapolate these studies to the clinical realm. In
contrast, the porcine heart has remarkably similar coronary
anatomy to that of human subjects and as such represents a
more clinically relevant model.
In this study we found that tepid perfusion permitted an
earlier recovery of aerobic metabolism compared with stan-
dard hypothermic temperatures. Unfortunately, we were
unable to demonstrate a difference in either lactate release
or acid release between groups, although there was a trend
toward less acidosis in the tepid group (P = .07). At cross-
clamp release, hearts in the cold group displayed twice as
much lactate release as those in the tepid group (1.6 ± 0.3
vs 0.8 ± 0.4 mmol/L, P = .04). Although this difference did
not persist during reperfusion, we have previously shown
that early lactate release within the first 5 minutes of reper-
fusion can predict the development of postischemic ven-
tricular dysfunction.20 Therefore, strategies aimed at stim-
ulating aerobic metabolism during this critical phase of
reperfusion may have significant effects on myocardial
function. The major metabolic difference between groups
remained the increased oxygen extraction at all time points
in the tepid group. The improved aerobic capacity in the
tepid group resulted in significantly greater functional
recovery (Figure 2).
In summary, continuous coronary perfusion during allo-
graft storage enabled successful transplantation while
avoiding the detrimental effects of profound hypothermia.
Refinements to both perfusate composition and delivery
may further enhance myocardial tolerance to prolonged
ischemia and hopefully improve both the short- and long-
term outcomes of clinical heart transplantation.
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